Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial

What is a clinically relevant change on the HIT-6 questionnaire? An estimation in a primary-care population of migraine patients

(2013) Antonia FH Smelt et al.   CEPHALALGIA

Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society

(2013) P. C. Tfelt-Hansen   NEUROLOGY

Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Table 1

(2012) S.D. Silberstein et al.   NEUROLOGY

A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine

(2011) Shalonda K Slater et al.   CEPHALALGIA

Medium-dose riboflavin as a prophylactic agent in children with migraine: A preliminary placebo-controlled, randomised, double-blind, cross-over trial

(2010) Jacques Bruijn et al.   CEPHALALGIA

Use of Complementary and Alternative Medicine in Patients Suffering from Primary Headache Disorders

(2009) C Gaul et al.   CEPHALALGIA

Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs

(2009) C. Di Lorenzo et al.   NEUROLOGY

High-Dose Ribof lavin for Migraine Prophylaxis in Children: A Double-Blind, Randomized, Placebo-Controlled Trial

(2008) Suzanna C. MacLennan et al.   JOURNAL OF CHILD NEUROLOGY